SERINC5, serine incorporator 5, 256987

N. diseases: 8; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0474808
Disease: Follicular neoplasm
Follicular neoplasm
0.010 Biomarker disease BEFREE The ratio tpo2 or tpo3 to tpo1 was inversed in follicular tumors. 16728576 2006
CUI: C0006012
Disease: Borderline Personality Disorder
Borderline Personality Disorder
0.010 Biomarker disease BEFREE We present results from a first genome-wide association study of BP features, which shows a promising signal on chromosome 5 corresponding to SERINC5, a protein involved in myelination. 23979607 2014
Human immunodeficiency virus (HIV) II infection category B1
0.040 AlteredExpression disease BEFREE Importantly, only Ser5-001 shows strong anti-HIV-1 activity. 28275190 2017
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.020 Biomarker disease BEFREE The viral restriction factor SERINC5 inhibits HIV-1 infection via unknown mechanisms. 28389578 2017
CUI: C0272178
Disease: Drug-induced neutropenia
Drug-induced neutropenia
0.100 GeneticVariation disease GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 Biomarker disease BEFREE SERINC5 as a New Restriction Factor for Human Immunodeficiency Virus and Murine Leukemia Virus. 30265629 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 Biomarker disease BEFREE We conclude that Nef uses a similar mechanism to downregulate Ser5 and CD4, which sorts Ser5 into a point-of-no-return degradative pathway to counteract its restriction.<b>IMPORTANCE</b> Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) express an accessory protein called Nef to promote viral pathogenesis. 29514909 2018
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.020 Biomarker disease BEFREE Collectively, these results provide new insights into our ongoing understanding of the Nef-Ser5 arms race in HIV-1 infection. 29514909 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 AlteredExpression disease BEFREE In the absence of viral antagonists, rodent and lagomorph SERINC3 and SERINC5 displayed anti-HIV activity in a similar range to human controls. 30566072 2019
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. 31186327 2019
CUI: C0035369
Disease: Retroviridae Infections
Retroviridae Infections
0.010 Biomarker group BEFREE Because tier 1 and tier 2/3 Env trimers have open and closed conformations, respectively, and CD4 opens the closed conformation, we conclude that SERINC5 selectively dissociates Env trimers with an open conformation to restrict HIV-1 replication.<b>IMPORTANCE</b> Restriction factors provide the first line of defense against retrovirus infection by posing several blocks to the viral replication cycle. 31043528 2019
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 Biomarker disease BEFREE SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. 31186327 2019